Interferon alpha-2a treatment for refractory Behcet uveitis in Korean patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2415
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Interferon alpha-2a treatment for refractory Behcet uveitis in Korean patients ; volume:18 ; number:1 ; day:20 ; month:2 ; year:2018 ; pages:1-4 ; date:12.2018
BMC ophthalmology ; 18, Heft 1 (20.2.2018), 1-4, 12.2018
- Schlagwort
-
Augenheilkunde
Augenkrankheit
- Urheber
-
Lee, Ji Hwan
- Beteiligte Personen und Organisationen
-
Lee, Christopher Seungkyu
Lee, Sung Chul
SpringerLink (Online service)
- DOI
-
10.1186/s12886-018-0719-0
- URN
-
urn:nbn:de:1111-2018041527425
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lee, Ji Hwan
- Lee, Christopher Seungkyu
- Lee, Sung Chul
- SpringerLink (Online service)
Ähnliche Objekte (12)
A 10-year follow-up of infliximab monotherapy for refractory uveitis in Behçet’s syndrome
Early administration of adalimumab for paediatric uveitis due to Behçet’s disease
Decoding Behcet’s Uveitis: an In-depth review of pathogenesis and therapeutic advances
Decreased interleukin 27 expression is associated with active uveitis in Behçet’s disease
Sex-specific circulating unconventional neutrophils determine immunological outcome of auto-inflammatory Behçet’s uveitis
Cataract surgery combined with micro-incision vitrectomy in patients with behcet’s disease uveitis
Conventional immunosuppressive therapy in severe Behcet’s Uveitis: the switch rate to the biological agents
Association between subfoveal choroidal thickness and leakage site on fluorescein angiography in Behçet’s uveitis
Quantitative urinary proteome analysis reveals potential biomarkers for disease activity of Behcet’s disease uveitis
Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet’s disease
Experience of using adalimumab in treating sight-threatening paediatric or adolescent Behcet’s disease-related uveitis
Role of Adalimumab Biosimilar in the Treatment of Non-Anterior Uveitis Associated with Behçet’s Syndrome
A 10-year follow-up of infliximab monotherapy for refractory uveitis in Behçet’s syndrome
Early administration of adalimumab for paediatric uveitis due to Behçet’s disease
Decoding Behcet’s Uveitis: an In-depth review of pathogenesis and therapeutic advances
Decreased interleukin 27 expression is associated with active uveitis in Behçet’s disease
Sex-specific circulating unconventional neutrophils determine immunological outcome of auto-inflammatory Behçet’s uveitis
Cataract surgery combined with micro-incision vitrectomy in patients with behcet’s disease uveitis
Conventional immunosuppressive therapy in severe Behcet’s Uveitis: the switch rate to the biological agents
Association between subfoveal choroidal thickness and leakage site on fluorescein angiography in Behçet’s uveitis
Quantitative urinary proteome analysis reveals potential biomarkers for disease activity of Behcet’s disease uveitis
Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet’s disease
Experience of using adalimumab in treating sight-threatening paediatric or adolescent Behcet’s disease-related uveitis
Role of Adalimumab Biosimilar in the Treatment of Non-Anterior Uveitis Associated with Behçet’s Syndrome
A 10-year follow-up of infliximab monotherapy for refractory uveitis in Behçet’s syndrome
Early administration of adalimumab for paediatric uveitis due to Behçet’s disease
Decoding Behcet’s Uveitis: an In-depth review of pathogenesis and therapeutic advances
Decreased interleukin 27 expression is associated with active uveitis in Behçet’s disease
Sex-specific circulating unconventional neutrophils determine immunological outcome of auto-inflammatory Behçet’s uveitis
Cataract surgery combined with micro-incision vitrectomy in patients with behcet’s disease uveitis
Conventional immunosuppressive therapy in severe Behcet’s Uveitis: the switch rate to the biological agents
Association between subfoveal choroidal thickness and leakage site on fluorescein angiography in Behçet’s uveitis
Quantitative urinary proteome analysis reveals potential biomarkers for disease activity of Behcet’s disease uveitis
Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet’s disease
Experience of using adalimumab in treating sight-threatening paediatric or adolescent Behcet’s disease-related uveitis